Legato Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,644
Closed -$2.41M 805
2026
Q1
$2.41M Buy
40,644
+12,870
+46% +$835K 0.22% 136
2025
Q4
$1.71M Buy
27,774
+23,382
+532% +$1.43M 0.15% 216
2025
Q3
$274K Hold
4,392
0.03% 497
2025
Q2
$351K Hold
4,392
0.04% 483
2025
Q1
$378K Sell
4,392
-1,440
-25% -$118K 0.05% 462
2024
Q4
$455K Hold
5,832
0.06% 454
2024
Q3
$420K Sell
5,832
-12,719
-69% -$901K 0.05% 464
2024
Q2
$1.28M Sell
18,551
-18,331
-50% -$1.24M 0.17% 197
2024
Q1
$2.68M Buy
36,882
+715
+2% +$47.8K 0.32% 84
2023
Q4
$2.21M Buy
36,167
+7,642
+27% +$454K 0.29% 99
2023
Q3
$1.63M Buy
28,525
+9,574
+51% +$579K 0.24% 137
2023
Q2
$1.13M Sell
18,951
-2,542
-12% -$152K 0.15% 225
2023
Q1
$1.35M Sell
21,493
-3,346
-13% -$209K 0.24% 133
2022
Q4
$1.55M Buy
+24,839
New +$1.42M 0.3% 101

Other funds holding PBH

Legato Capital Management's PBH Position: Q2 2026 in Review

Legato Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 40,644 shares — an estimated $2.41M sold.

Legato Capital Management first reported a position in PBH in Q4 2022 and held it in 14 quarters. The position peaked at $2.68M in Q1 2024. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Legato Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Legato Capital Management sold 40,644 Prestige Consumer Healthcare shares in Q2 2026, an estimated $2.41M.
  • Legato Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2022 and held it in 14 quarters.
  • Legato Capital Management's Prestige Consumer Healthcare position peaked at $2.68M in Q1 2024.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.